In response to the continuing scarcity of ADHD drugs, the U.S. Food and Drug Administration (FDA) has accepted a number of generic variations of Vyvanse (lisdexamfetamine dimesylate) for the remedy of attention-deficit/hyperactivity dysfunction in folks 6 years and older.
Vyvanse is out there in capsules and chewable tablets, based on the FDA’s announcement.
Dr. Barry Okay. Herman, a board-certified psychiatrist and the chief medical officer for Mentavi Health, a psychological well being evaluation supplier in Grand Rapids, Michigan, is hopeful that these new generic medication will assist handle the persistent ADHD medicine scarcity.
ADHD DRUG SHORTAGE COULD MAKE BACK-TO-SCHOOL SEASON CHALLENGING, EXPERT SAYS: ‘WIDESPREAD IMPACT’
“The FDA made the review and approval of these generics a priority, and hopefully manufacturing will now scale up rapidly to meet this pressing need,” he advised Fox News Digital.
These generic medicines are designed to work in the identical means and supply the identical profit because the brand-name variations.
“Generic drugs are approved based on their bioequivalence to the brand drug,” Herman mentioned. “In theory, that would make them work the same, but in some cases, patients may feel that they do better on the branded drug.”
ADHD NUMBERS CLIMBING DRAMATICALLY IN THE U.S., ESPECIALLY AMONG WOMEN, SAYS NEW STUDY
Potential unwanted side effects are probably the identical as with the brand-name drug, he famous, although some could expertise completely different unwanted side effects on the generic version.
Fourteen firms have now been accepted to fabricate and promote generic Vyvanse.
“That should help address the medication shortage, especially of Adderall,” Herman mentioned. “It may take some time, however, for the manufacturing and distribution of the generic drug to catch up to the shortage.”
The value of the generic Vyvanse ought to be significantly lower than the brand-name ADHD medication, Herman mentioned.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Having many companies manufacture and sell the drug will generally drive the cost down,” he mentioned. “Costs may differ depending on whether you have insurance, the pharmacy you use and the dose of the drug.”
The FDA first introduced the scarcity of ADHD medicine — primarily Adderall — in October 2022.
Adderall (amphetamine combined salts) is the medicine that is most affected by the scarcity, together with variations of methylphenidate, bought beneath the model names Ritalin or Concerta.
Vyvanse can also be meant to deal with average to extreme binge-eating dysfunction (BED) in adults.
CLICK HERE TO GET THE FOX NEWS APP
“This should help many people who are currently struggling with the drug shortage,” mentioned Herman.
“Having a generic drug available that is approved for both ADHD ages 6 and up, and for adults with moderate to severe binge-eating disorder, could not come at a more opportune time.”